Brief: Cero Therapeutics Announces Tristar Centennial Medical Center As A Clinical Trial Site For Its Phase 1 Clinical Trial Of Cer-1236 In Acute Myeloid Leukemia
30/04/2025 13:19
April 30 (Reuters) - CERo Therapeutics Holdings Inc CERO.O: CERO THERAPEUTICS HOLDINGS, INC. ANNOUNCES TRISTAR CENTENNIAL MEDICAL CENTER AS A CLINICAL TRIAL SITE FOR ITS PHASE 1 CLINICAL TRIAL OF CER-1236 IN ACUTE MYELOID LEUKEMIA Source text: ID:nGNX8xCDJQ Further company coverage: CERO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CERo Therapeutics Holdings
See all newsBrief: Cero Therapeutics Hearing Review Council Issued Decision
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml (Certaint-1)
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Clinical Trial
Brief: Cero Therapeutics Holdings Inc - Continues To Evaluate Additional Options For Up-List